#Mexico #Mexico City #dividend payment #Genomma Lab

Genomma Lab Internacional Announces Eleventh Dividend Payment

Genomma Lab Internacional, S.A.B. de C.V., commonly known as Genomma Lab, has officially announced its eleventh dividend payment, marking a notable milestone for the company as it continues its trajectory as a leader in the pharmaceutical and personal care sectors. This announcement was made on March 6, 2025, and comes as a part of the company's commitment to delivering value to its shareholders.

Dividend Details

The company has declared a cash dividend of $0.20 Mexican pesos per share on its common stock. This decision translates to a substantial total payout of $200 million pesos, emphasizing the company’s robust financial health and operational success. The dividends will be issued to shareholders who hold the applicable circulating shares as of the close of business on March 14, 2025. The Board of Directors made this decision during the Annual General Shareholders Meeting held on April 30, 2024, acknowledging the company’s strong performance and market positioning.

Future Dividend Plans

Moving forward, Genomma Lab intends to continue rewarding its stakeholders through regular dividend payments, setting a strategic goal to perform these distributions on a quarterly basis. This approach demonstrates the company’s confidence in sustainable business growth and profitability, as well as its commitment to enhancing shareholder value.

About Genomma Lab Internacional

Founded in Mexico, Genomma Lab Internacional has quickly risen to become one of the most prominent pharmaceutical and personal care product firms in Latin America. The company is well-recognized for its diverse portfolio of premium branded products that lead the market in sales and share. Genomma Lab prides itself on its innovative product development process, effective consumer-oriented marketing strategies, and a highly efficient supply chain management model.

The company's extensive retail distribution network enhances its reach not only in Mexico but increasingly across international markets, allowing it to serve a broader consumer base. With a potent combination of innovation, quality, and market insight, Genomma Lab has carved a significant niche within the competitive landscape of its industry.

A Forward-Looking Perspective

The latest announcement marks another step in Genomma Lab’s journey and is indicative of the broader financial strategies being deployed to navigate future market uncertainties. The company notes that financial projections and forecasts made in their statements are subject to various factors, including economic fluctuations, competitive pressures, and changes in consumer trends. Therefore, stakeholders are advised to remain cognizant of these dynamics as Genomma Lab continues to adapt and thrive in the evolving marketplace.

For further information, shareholders and interested parties can visit Genomma Lab's official website at www.genommalab.com. Their shares are publicly traded on the Mexican Stock Exchange under the ticker symbol LABB.

As Genomma Lab steps into the future, its steadfast commitment to growth and shareholder satisfaction positions it as a business to watch, making this dividend announcement just one chapter in its ongoing success story.